0001628280-24-008116 Sample Contracts

Twelfth Amendment to License Agreement

License Agreement • March 1st, 2024 • Prime Medicine, Inc. • Biological products, (no disgnostic substances)

• Contract Type
  License Agreement
• Filed
  March 1st, 2024
• Company
  Prime Medicine, Inc.
• Industry
  Biological products, (no disgnostic substances)

This Twelfth Amendment to License Agreement (“Twelfth Amendment”) is dated October 2, 2023 (“Effective Date”) and entered into by and between Prime Medicine, Inc. (“Licensee”) and MIL 21E, LLC (“Licensor”).